Patterns of COVID-19-related headache: A cross-sectional study

Sahin, BE.; Çelikbilek, Asuman; Koçak, Yavuz; Hızmalı, Lokman

doi:10.1016/j.clineuro.2022.107339

Cited by 7 publications

(12 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Early data have shown that headache was commonly found in Omicron variant [12], while recent data from the ZOE COVID study report a higher prevalence of dizzy or light headed, headache and brain fog in Delta versus Omicron variant [11 & ]. Headache is usually described as moderate or severe, diffuse and oppressive (75% of cases described as tension-type headache (TTH)-like) although sometimes it has been described with migraine-like characteristics such as throbbing pain that gets worse with movement, nausea, vomiting and photo or phonophobia, especially in patients with a previous history of migraine [13,14].…”

Section: Headache As a Symptom Of Acute Coronavirus Disease 2019mentioning

confidence: 99%

“…Headache is usually described as moderate or severe, diffuse and oppressive (75% of cases described as tension-type headache (TTH)-like) although sometimes it has been described with migraine-like characteristics such as throbbing pain that gets worse with movement, nausea, vomiting and photo or phonophobia, especially in patients with a previous history of migraine [13,14].…”

Section: Headache As a Symptom Of Acute Coronavirus Disease 2019mentioning

confidence: 99%

See 1 more Smart Citation

Long COVID and especially headache syndromes

Tana¹,

Giamberardino

Martelletti³

2023

Current Opinion in Neurology

View full text Add to dashboard Cite

Purpose of reviewThis is an expert overview on recent literature about the complex relationship between coronavirus disease 2019 (COVID-19) and headache. Recent findingsLong COVID is a clinical syndrome characterized by the presence of persistent symptoms following the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Headache is one of the most common symptoms and is described most often as throbbing pain, associated with photo and phonofobia and worsening with physical exercise. In acute COVID-19, headache is usually described as moderate or severe, diffuse and oppressive although sometimes it has been described with a migraine-like phenotype, especially in patients with a previous history of migraine. Headache intensity during acute phase seems to be the most important predictor of duration of headache over time. Some COVID-19 cases can be associated with cerebrovascular complications, and red flags of secondary headaches (e.g. new worsening or unresponsive headache, or new onset of neurological focal signs) should be urgently investigated with imaging. Treatment goals are the reduction of number and intensity of headache crises, and the prevention of chronic forms.

show abstract

Section: Headache As a Symptom Of Acute Coronavirus Disease 2019mentioning

confidence: 99%

Section: Headache As a Symptom Of Acute Coronavirus Disease 2019mentioning

confidence: 99%

Long COVID and especially headache syndromes

Tana¹,

Giamberardino

Martelletti³

2023

Current Opinion in Neurology

View full text Add to dashboard Cite

show abstract

“…The virus is thought to cause neurologic impairment directly by damaging the neuronal pathway and indirectly through hypoxia, hypertension, coagulopathy, cytokine storm in the CNS, and worsening preexisting conditions 18. Headache is a common symptom of COVID-19 infection and often is resistant to typical treatment methods including acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and classic migraine medications 19. Headache also is a prevalent symptom in PASC, affecting 10.6% of patients at 90 days after acute infection 20.…”

Section: Cns and Neurocognitive Complicationsmentioning

confidence: 99%

“…No consensus exists about effective treatment for headaches related to COVID-19 because they often are refractory to typically recommended treatments. Headache associated with COVID-19 has been shown to have only a partial response to first-line analgesics 19…”

Section: Cns and Neurocognitive Complicationsmentioning

confidence: 99%

“…18 Headache is a common symptom of COVID-19 infection and often is resistant to typical treatment methods including acetaminophen, nonsteroidal antiinflammatory drugs (NSAIDs), and classic migraine medications. 19 Headache also is a prevalent symptom in PASC, affecting 10.6% of patients at 90 days after acute infection. 20 A recent meta-analysis showed that the prevalence of persistent headache in patients who have recovered from COVID-19 infection was 8% to 15% in the first 6 months.…”

Section: Cns and Neurocognitive Complicationsmentioning

confidence: 99%

See 1 more Smart Citation